These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 35568682)

  • 1. Functional profiling of LDLR variants: Important evidence for variant classification: Functional profiling of LDLR variants.
    Graça R; Alves AC; Zimon M; Pepperkok R; Bourbon M
    J Clin Lipidol; 2022; 16(4):516-524. PubMed ID: 35568682
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LDLR variants functional characterization: Contribution to variant classification.
    Alves AC; Azevedo S; Benito-Vicente A; Graça R; Galicia-Garcia U; Barros P; Jordan P; Martin C; Bourbon M
    Atherosclerosis; 2021 Jul; 329():14-21. PubMed ID: 34167030
    [TBL] [Abstract][Full Text] [Related]  

  • 3. p.(Asp47Asn) and p.(Thr62Met): non deleterious LDL receptor missense variants functionally characterized in vitro.
    Benito-Vicente A; Siddiqi H; Uribe KB; Jebari S; Galicia-Garcia U; Larrea-Sebal A; Stef M; Ostolaza H; Palacios L; Martin C
    Sci Rep; 2018 Nov; 8(1):16614. PubMed ID: 30413722
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional analysis of new variants at the low-density lipoprotein receptor associated with familial hypercholesterolemia.
    Rodríguez-Jiménez C; Pernía O; Mostaza J; Rodríguez-Antolín C; de Dios García-Díaz J; Alonso-Cerezo C; García-Polo I; Blanco A; Lahoz C; Arrieta F; Beltrán L; Díaz de Bustamante A; Garzón-Lorenzo L; Álvarez-Sala LA; Asenjo Á; Ibáñez de Cáceres I; Rodríguez-Nóvoa S
    Hum Mutat; 2019 Aug; 40(8):1181-1190. PubMed ID: 31106925
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional analysis of six uncharacterised mutations in LDLR gene.
    Gomez A; Colombo R; Pontoglio A; Helman L; Kaeser L; Giunta G; Parolin ML; Toscanini U; Cuniberti L
    Atherosclerosis; 2019 Dec; 291():44-51. PubMed ID: 31689621
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Replacement of cysteine at position 46 in the first cysteine-rich repeat of the LDL receptor impairs apolipoprotein recognition.
    Benito-Vicente A; Uribe KB; Siddiqi H; Jebari S; Galicia-Garcia U; Larrea-Sebal A; Cenarro A; Stef M; Ostolaza H; Civeira F; Palacios L; Martin C
    PLoS One; 2018; 13(10):e0204771. PubMed ID: 30332439
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutation type classification and pathogenicity assignment of sixteen missense variants located in the EGF-precursor homology domain of the LDLR.
    Galicia-Garcia U; Benito-Vicente A; Uribe KB; Jebari S; Larrea-Sebal A; Alonso-Estrada R; Aguilo-Arce J; Ostolaza H; Palacios L; Martin C
    Sci Rep; 2020 Feb; 10(1):1727. PubMed ID: 32015373
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of LDLR variants from homozygous FH patients carrying multiple mutations in the LDLR gene.
    Jiang L; Benito-Vicente A; Tang L; Etxebarria A; Cui W; Uribe KB; Pan XD; Ostolaza H; Yang SW; Zhou YJ; Martin C; Wang LY
    Atherosclerosis; 2017 Aug; 263():163-170. PubMed ID: 28645073
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activity-associated effect of LDL receptor missense variants located in the cysteine-rich repeats.
    Etxebarria A; Benito-Vicente A; Stef M; Ostolaza H; Palacios L; Martin C
    Atherosclerosis; 2015 Feb; 238(2):304-12. PubMed ID: 25545329
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Familial hypercholesterolemia: A single-nucleotide variant (SNV) in mosaic at the low density lipoprotein receptor (LDLR).
    Rodríguez-Nóvoa S; Rodríguez-Jiménez C; Alonso C; Rodriguez-Laguna L; Gordo G; Martinez-Glez V; García Polo I
    Atherosclerosis; 2020 Oct; 311():37-43. PubMed ID: 32937241
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel combined variants of LDLR and LDLRAP1 genes causing severe familial hypercholesterolemia.
    Alnouri F; Athar M; Al-Allaf FA; Abduljaleel Z; Taher MM; Bouazzaoui A; Al Ammari D; Karrar H; Albabtain M
    Atherosclerosis; 2018 Oct; 277():425-433. PubMed ID: 30270081
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional Analysis of LDLR (Low-Density Lipoprotein Receptor) Variants in Patient Lymphocytes to Assess the Effect of Evinacumab in Homozygous Familial Hypercholesterolemia Patients With a Spectrum of LDLR Activity.
    Banerjee P; Chan KC; Tarabocchia M; Benito-Vicente A; Alves AC; Uribe KB; Bourbon M; Skiba PJ; Pordy R; Gipe DA; Gaudet D; Martin C
    Arterioscler Thromb Vasc Biol; 2019 Nov; 39(11):2248-2260. PubMed ID: 31578082
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systematic prediction of familial hypercholesterolemia caused by low-density lipoprotein receptor missense mutations.
    Guo J; Gao Y; Li X; He Y; Zheng X; Bi J; Hou L; Sa Y; Zhang M; Yin H; Jiang L
    Atherosclerosis; 2019 Feb; 281():1-8. PubMed ID: 30583242
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of publicly available LDLR, APOB, and PCSK9 variants associated with familial hypercholesterolemia: application of ACMG guidelines and implications for familial hypercholesterolemia diagnosis.
    Chora JR; Medeiros AM; Alves AC; Bourbon M
    Genet Med; 2018 Jun; 20(6):591-598. PubMed ID: 29261184
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Compound heterozygous LDLR variant in severely affected familial hypercholesterolemia patient.
    Al-Allaf FA; Alashwal A; Abduljaleel Z; Taher MM; Bouazzaoui A; Abalkhail H; Al-Allaf AF; Athar M
    Acta Biochim Pol; 2017; 64(1):75-79. PubMed ID: 27878139
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro functional characterization of missense mutations in the LDLR gene.
    Silva S; Alves AC; Patel D; Malhó R; Soutar AK; Bourbon M
    Atherosclerosis; 2012 Nov; 225(1):128-34. PubMed ID: 23021490
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional characterization and classification of frequent low-density lipoprotein receptor variants.
    Etxebarria A; Benito-Vicente A; Palacios L; Stef M; Cenarro A; Civeira F; Ostolaza H; Martin C
    Hum Mutat; 2015 Jan; 36(1):129-41. PubMed ID: 25378237
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Refinement of pathogenicity classification of variants associated with familial hypercholesterolemia: Implications for clinical diagnosis.
    Di Costanzo A; Minicocci I; D'Erasmo L; Commodari D; Covino S; Bini S; Ghadiri A; Ceci F; Maranghi M; Catapano AL; Gazzotti M; Casula M; Montali A; Arca M
    J Clin Lipidol; 2021; 15(6):822-831. PubMed ID: 34756585
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Validation of LDLr Activity as a Tool to Improve Genetic Diagnosis of Familial Hypercholesterolemia: A Retrospective on Functional Characterization of LDLr Variants.
    Benito-Vicente A; Uribe KB; Jebari S; Galicia-Garcia U; Ostolaza H; Martin C
    Int J Mol Sci; 2018 Jun; 19(6):. PubMed ID: 29874871
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel low-density lipoprotein receptor variant in a Ukrainian patient: a case report and overview of the disease-causing low-density lipoprotein receptor variants associated to familial hypercholesterolemia.
    Moffa S; Onori ME; De Paolis E; Ricciardi Tenore C; Perrucci A; Pontecorvi A; Giaccari A; Urbani A; Minucci A
    Mol Biol Rep; 2022 Feb; 49(2):1623-1630. PubMed ID: 34846648
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.